Ses of noninvasive breast cancer among women assigned to the tamoxifen
Ses of noninvasive breast cancer amongst females assigned towards the tamoxifen arm and 80 instances amongst these assigned to raloxifene (RR =1.40; 95 CI: 0.98 to 2.00). There were fewer…